Duty Stuart
SEC insider (Form 3/4/5 filer). CIK 0001970274. Director at Foghorn Therapeutics Inc. (FHTX) and 3 other issuers. 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 24, 2026. Located in MONTREAL.
Companies Duty Stuart has filed insider reports for
- Foghorn Therapeutics Inc. (FHTX): Director
- Milestone Pharmaceuticals Inc. (MIST): Director
- EyePoint, Inc. (EYPT): Director
- ACHIEVE LIFE SCIENCES, INC. (ACHV): Director
Duty Stuart
CIK: 0001970274
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 24, 2026FHTX
Foghorn Therapeutics Inc.
AwardDirectStock Options (Right to buy)
28K shares at avg. $4.08- - Jun 10, 2026MIST
Milestone Pharmaceuticals Inc.
AwardDirectStock Option (right to buy)
77K shares- - Jan 2, 2026EYPT
EyePoint, Inc.
AwardDirectStock Option (Right to Buy)
40K shares- - Jun 10, 2025MIST
Milestone Pharmaceuticals Inc.
AwardDirectStock Option (right to buy)
40K shares- - Jun 6, 2025ACHV
ACHIEVE LIFE SCIENCES, INC.
AwardDirectStock Option (right to buy)
31.5K shares- - May 1, 2025FHTX
Foghorn Therapeutics Inc.
AwardDirectStock Options (Right to buy)
50K shares at avg. $4.16- - Jan 3, 2025EYPT
EyePoint Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
40K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 24, 2026 |  FHTX Foghorn Therapeutics Inc. | Award Stock Options (Right to buy) | 28,000 | $4.08 | - | Direct |
| Jun 10, 2026 |  MIST Milestone Pharmaceuticals Inc. | Award Stock Option (right to buy) | 77,000 | - | - | Direct |
| Jan 2, 2026 |  EYPT EyePoint, Inc. | Award Stock Option (Right to Buy) | 40,000 | - | - | Direct |
| Jun 10, 2025 | MIST Milestone Pharmaceuticals Inc. | Award Stock Option (right to buy) | 40,000 | - | - | Direct |
| Jun 6, 2025 |  ACHV ACHIEVE LIFE SCIENCES, INC. | Award Stock Option (right to buy) | 31,500 | - | - | Direct |
| May 1, 2025 | FHTX Foghorn Therapeutics Inc. | Award Stock Options (Right to buy) | 50,000 | $4.16 | - | Direct |
| Jan 3, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 40,000 | - | - | Direct |
1-7 of 7 transactions